Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin Nasal Rinses for COVID-19 Mediated Dysosmia
NCT05542095Phase 1Withdrawn
- Sponsor
- Washington University School of Medicine
- Start
- May 2023
- Primary completion
- May 2023
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of simvastatin in Olfactory dysfunction (4 arms), sponsored by Washington University School of Medicine. Primary endpoint: Safety and feasibility of simvastatin nasal wash at 4 weeks. Planned start May 2023; status: withdrawn.
02
Drugs
simvastatin
03
Conditions
Olfactory dysfunction
Beyond the preview
Go deeper on NCT05542095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05542095.